Cleaning, Contamination & Cross-Contamination Control – Page 28

Dedicated vs Shared Facility Decision Criteria for High-Risk Products

Before looking into root causes, it’s vital to identify key symptoms that may indicate risks associated with shared facilities. Common signals include:Click to read the full article.

Worst-Case Product Selection Based on Toxicity, Solubility, Cleanability, and Dose

Identifying the symptoms of inadequate product selection is the first step in addressing cleaning validation challenges. Typical signals may include:Click to read the full article.

Shared Facility Controls for Potent APIs and Hormonal Products

Identifying early warning signs of contamination is critical in shared facilities. Symptoms may manifest in various ways:Click to read the full article.

Why the Lowest MACO Product Is Not Always the Worst-Case Product

Identifying symptoms that may indicate inappropriate selection of worst-case products is critical in maintaining compliance and product safety. Below are several signals that may warrant further investigation:Click to read the…

How to Use HBEL and PDE in Shared Facility Risk Assessment

Implementing Risk Management Strategies in Shared Facilities Using HBEL and PDE In the landscape of pharmaceutical manufacturing, shared facility environments pose a unique set of risks, particularly when it comes…

Common Errors in Worst-Case Product Selection During Cleaning Validation

Identifying the symptoms that signal potential issues in cleaning validation begins at the source—manufacturing operations and laboratory evaluations. Some indicators include:Click to read the full article.

Risk-Based Segregation Strategy for Shared Manufacturing Areas

Identifying the initial symptoms of contamination or cross-contamination is critical in shared manufacturing areas. Common signals include:Click to read the full article.

Worst-Case Product Selection for Multiproduct OSD Manufacturing Facilities

Identifying symptoms of inadequate worst-case product selection early is essential for maintaining product integrity and quality. Key indicators may include:Click to read the full article.

Shared Facility Cleaning Validation Requirements for GMP Compliance

Typical symptoms indicating possible issues with cleaning validation in shared facilities often manifest as unexpected findings during routine monitoring or an increase in batch deviations. Such signals may include:Click to…

Worst-Case Product Selection for Injectable Manufacturing and Fill-Finish Lines

Identifying symptoms of poor worst-case product selection early can prevent more severe issues in pharmaceutical manufacturing. Symptoms may manifest in various forms, including:Click to read the full article.

How to Prevent Product Carryover in Shared Equipment Trains

Strategies for Preventing Product Carryover in Shared Manufacturing Equipment Product carryover in shared manufacturing equipment poses a significant risk to pharmaceutical quality and safety. This issue becomes especially critical in…

Worst-Case Product Selection for API Plants: Potency, Solubility, and Process Residues

Identifying problematic symptoms related to worst-case product selection is the first step in effectively managing contamination risks.Click to read the full article.